Title of Collaborative Activity:
SARS-CoV-2 Antiviral Summit
Description of Collaborative Activity:
Organized a summit on SARS-CoV-2 antiviral therapeutics, held Nov 2020, with summit report released Jan 2020
Type of Collaborative Activity:
Meeting/ Workshop
Year the Collaborative Activity Originated:
2020
NIH Participating Institutes/Centers/Office of the Director:
NCATS
HHS Agency Collaborators on this Activity:
FDA
